陨灶贼 允 韵责澡贼澡葬造皂燥造熏 灾燥造援 9熏 晕燥援 8熏 Aug.18, 圆园16 www. ijo. cn 栽藻造押8629原愿圆圆源缘员苑圆 8629-82210956 耘皂葬蚤造押ijopress岳员远猿援糟燥皂
窑Review窑
Nanomedicine in the application of uveal melanoma Department of Endocrinology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China 2 Winship Cancer Institute, School of Medicine, Emory University, Atlanta, Georgia 30322, USA 3 Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China 4 Department of Ophthalmology, School of Medicine, Emory University, Atlanta, Georgia 30322, USA 5 Department of Pathology, School of Medicine, Emory University, Atlanta, Georgia 30322, USA 6 State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, Sichuan Province, China Correspondence to: Qing Zhang. Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China. [email protected] Received: 2015-10-28 Accepted: 2016-02-16 1
Abstract
· Rapid
advances in nanomedicine have significantly
changed many aspects of nanoparticle application to the eye including areas of diagnosis, imaging and more importantly drug delivery. The nanoparticle -based drug
delivery systems has provided a solution to various drug solubility -related problems in ophthalmology treatment. Nanostructured compounds could be used to achieve local ocular delivery with minimal unwanted systematic side effects produced by taking advantage of the
phagocyte system. In addition, the control release by nanomaterials encapsulated drugs provides prolong exposure of the compound in the body. Furthermore, certain nanoparticles can overcome important body
barriers including the blood-retinal barrier as well as the corneal-retinal barrier of the eye for effective delivery of the drug. In summary, the nanotechnology based drug delivery system may serve as an important tool for uveal melanoma treatment.
·KEYWORDS: nanomedicine; nanoparticles; gene delivery; drug delivery; uveal melanoma DOI:10.18240/ijo.2016.08.20 You S, Luo J, Grossniklaus HE, Gou ML, Meng K, Zhang Q. Nanomedicine in the application of uveal melanoma. 2016;9(8):1215-1225
INTRODUCTION OF UVEAL MELANOMA veal melanoma is the most common adult primary tumor of the eye. The pace of incidence increase of melanoma as a whole group in the USA has surpassed all other types of tumors within the last 20y [1]. The liver is the sole or initial site of tumor spread in more than 80% patients with uveal melanoma; once liver metastases have been diagnosed, the mean survival time drops to only 6-9mo, with a 5-year survival rate
窑Review窑
Nanomedicine in the application of uveal melanoma Department of Endocrinology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China 2 Winship Cancer Institute, School of Medicine, Emory University, Atlanta, Georgia 30322, USA 3 Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China 4 Department of Ophthalmology, School of Medicine, Emory University, Atlanta, Georgia 30322, USA 5 Department of Pathology, School of Medicine, Emory University, Atlanta, Georgia 30322, USA 6 State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, Sichuan Province, China Correspondence to: Qing Zhang. Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China. [email protected] Received: 2015-10-28 Accepted: 2016-02-16 1
Abstract
· Rapid
advances in nanomedicine have significantly
changed many aspects of nanoparticle application to the eye including areas of diagnosis, imaging and more importantly drug delivery. The nanoparticle -based drug
delivery systems has provided a solution to various drug solubility -related problems in ophthalmology treatment. Nanostructured compounds could be used to achieve local ocular delivery with minimal unwanted systematic side effects produced by taking advantage of the
phagocyte system. In addition, the control release by nanomaterials encapsulated drugs provides prolong exposure of the compound in the body. Furthermore, certain nanoparticles can overcome important body
barriers including the blood-retinal barrier as well as the corneal-retinal barrier of the eye for effective delivery of the drug. In summary, the nanotechnology based drug delivery system may serve as an important tool for uveal melanoma treatment.
·KEYWORDS: nanomedicine; nanoparticles; gene delivery; drug delivery; uveal melanoma DOI:10.18240/ijo.2016.08.20 You S, Luo J, Grossniklaus HE, Gou ML, Meng K, Zhang Q. Nanomedicine in the application of uveal melanoma. 2016;9(8):1215-1225
INTRODUCTION OF UVEAL MELANOMA veal melanoma is the most common adult primary tumor of the eye. The pace of incidence increase of melanoma as a whole group in the USA has surpassed all other types of tumors within the last 20y [1]. The liver is the sole or initial site of tumor spread in more than 80% patients with uveal melanoma; once liver metastases have been diagnosed, the mean survival time drops to only 6-9mo, with a 5-year survival rate
